natgillin/translations-raw huggingface dataset:
The financial contribution by the Union for the national programme referred to in Article 1 shall be granted provided that Bulgaria:
Finančni prispevek Unije za nacionalni program iz člena 1 se odobri, če Bolgarija:
implements the programme in accordance with the relevant provisions of Union law, including rules on competition and on the award of public contracts;
izvede program v skladu z ustreznimi določbami zakonodaje Unije, vključno s pravili o konkurenci in oddajo javnih naročil;
forwards to the Commission at the latest by 31 July 2010 the intermediate technical and financial reports for the programme referred to in Article 1, in accordance with Article 27(7)(a) of Decision 2009/470/EC;
Komisiji v skladu s členom 27(7)(a) Odločbe 2009/470/ES najpozneje do 31. julija 2010 pošlje vmesna tehnična in finančna poročila za program iz člena 1;
forwards to the Commission, in accordance with Article 27(7)(b) of Decision 2009/470/EC, by 30 April 2011 at the latest a final detailed technical report including the assessment of the results achieved and a detailed account of expenditure incurred from 1 January 2010 to 31 December 2010;
Komisiji v skladu s členom 27(7)(b) Odločbe 2009/470/ES najpozneje do 30. aprila 2011 pošlje končno podrobno tehnično poročilo, ki vključuje oceno doseženih rezultatov, in podroben obračun odhodkov, nastalih med 1. januarjem 2010 in 31. decembrom 2010;
forwards to the Commission, in accordance with Article 27(8) of Decision 2009/470/EC, by 30 April 2011 at the latest, the payment application related to the expenditure incurred in respect of the programme submitted on 17 September 2009;
Komisiji v skladu s členom 27(8) Odločbe 2009/470/ES najpozneje do 30. aprila 2011 pošlje zahtevek za plačilo, vezan na odhodke, ki so nastali s programom, predloženim 17. septembra 2009;
does not, for the programme referred to in Article 1, submit further requests for other Union contributions for these measures, and has not previously submitted such requests.
za program iz člena 1 ne predloži nadaljnjih zahtev za druge prispevke Unije za te ukrepe in takih zahtev ni predložila predhodno.
In case of late applications, the reductions of the financial contribution foreseen in Article 27(8) of Decision 2009/470/EC are applicable.
Pri zakasnelih zahtevkih se uporablja znižan finančni prispevek, kot je predvideno v členu 27(8) Odločbe 2009/470/ES.
This Decision shall apply from 1 January 2010.
Ta sklep se uporablja od 1. januarja 2010.
This Decision is addressed to the Republic of Bulgaria.
Ta sklep je naslovljen na Republiko Bolgarijo.
Done at Brussels, 17 December 2009.
V Bruslju, 17. decembra 2009
authorising a health claim on the effect of water-soluble tomato concentrate on platelet aggregation and granting the protection of proprietary data under Regulation (EC) No 1924/2006 of the European Parliament and of the Council
o odobritvi zdravstvenih trditev glede učinka v vodi topnega paradižnikovega koncentrata na agregacijo trombocitov in o odobritvi zakonske zaščite podatkov iz Uredbe (ES) št. 1924/2006 Evropskega parlamenta in Sveta
Having regard to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods [1], and in particular Article 18(4) thereof,
ob upoštevanju Uredbe (ES) št. 1924/2006 Evropskega parlamenta in Sveta z dne 20. decembra 2006 o prehranskih in zdravstvenih trditvah na živilih [1] ter zlasti člena 18(4) Uredbe,
Pursuant to Regulation (EC) No 1924/2006 health claims made on food are prohibited unless they are authorised by the Commission in accordance with that Regulation and included in a list of permitted claims.
Zdravstvene trditve na živilih so v skladu z Uredbo (ES) št. 1924/2006 prepovedane, razen če jih Komisija v skladu z navedeno uredbo odobri in uvrsti na seznam dovoljenih trditev.
Regulation (EC) No 1924/2006 also provides that applications for authorisations of health claims may be submitted by food business operators to the national competent authority of a Member State.
Uredba (ES) št. 1924/2006 določa tudi, da lahko nosilci živilske dejavnosti vloge za odobritev zdravstvenih trditev predložijo nacionalnemu pristojnemu organu države članice.
The national competent authority is to forward valid applications to the European Food Safety Authority (EFSA), hereinafter referred to as ‘the Authority’.
Nacionalni pristojni organ veljavne vloge pošlje Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija).
Following receipt of an application the Authority is to inform without delay the other Member States and the Commission and to deliver an opinion on a health claim concerned.
Agencija po prejemu vloge takoj obvesti druge države članice in Komisijo ter pripravi mnenje o zadevni zdravstveni trditvi.
The Commission is to decide on the authorisation of health claims taking into account the opinion delivered by the Authority.
Komisija ob upoštevanju mnenja Agencije odloči o odobritvi zdravstvenih trditev.
In order to stimulate innovation, health claims which are based on newly developed scientific evidence and/or which include a request for the protection of proprietary data shall undergo an accelerated type of authorisation.
Zaradi spodbujanja inovacij se zdravstvene trditve, ki temeljijo na novo ugotovljenih znanstvenih dokazih in/ali vključujejo zahtevo za zakonsko zaščito podatkov, odobrijo po hitrem postopku.
Where at the applicant’s request for the protection of proprietary data, the Commission proposes to restrict the use of such data in favour of the applicant, such restriction shall, in accordance with Article 21 of Regulation (EC) No 1924/2006 expire after 5 years.
Kadar na zahtevo vlagatelja za zakonsko zaščito podatkov Komisija predlaga omejitev uporabe takšnih podatkov v prid vlagatelja, takšna omejitev v skladu s členom 21 Uredbe (ES) št. 1924/2006 preneha veljati po petih letih.
Following an application from Provexis Natural Products Ltd, submitted on 7 January 2009 pursuant to Article 13(5) of Regulation (EC) No 1924/2006, the Authority was required to deliver an opinion on a health claim related to the effects of water-soluble tomato concentrate (WSTC) I and II on the blood platelet activity in healthy people (Question No EFSA-Q-2009-00229) [2].
Družba Provexis Natural Products Ltd. je 7. januarja 2009 v skladu s členom 13(5) Uredbe (ES) št. 1924/2006 predložila vlogo, Agencija pa je morala pripraviti mnenje o zdravstveni trditvi v zvezi z učinki v vodi topnega paradižnikovega koncentrata I in II na dejavnost trombocitov v krvi zdravih ljudi (vprašanje št. EFSA-Q-2009-00229) [2].
The claim proposed by the applicant was worded as follows: ‘Helps to maintain a healthy blood flow and benefits circulation’.
Vlagatelj je predlagal naslednjo trditev: „Pomaga ohraniti zdrav krvni obtok in je dober za prekrvavitev“.
On 28 May 2009, the Commission and the Member States received the scientific opinion from the Authority which concluded that on the basis of the data presented, a cause and effect relationship had been established between the consumption of WSTC I and II and helping to maintain normal platelet aggregation.
Komisija in države članice so 28. maja 2009 prejele znanstveno mnenje Agencije, ki je na podlagi predloženih podatkov ugotovila, da je vzročno-posledična povezava med uživanjem v vodi topnega paradižnikovega koncentrata I in II in navedeno trditvijo utemeljena ter da pomaga pri ohranjanju normalne agregacije trombocitov.
Subject to a revised wording, taking into account in particular the requirement referred to Article 5(2) of Regulation (EC) No 1924/2006, the claim should be considered as complying with the requirements of Regulation (EC) No 1924/2006, and it should be included in the Community list of permitted claims.
Trditev je ob spremembi besedila in upoštevanju zlasti zahteve iz člena 5(2) Uredbe (ES) št. 1924/2006 treba šteti za skladno z zahtevami iz Uredbe (ES) št. 1924/2006 ter jo uvrstiti na seznam dovoljenih trditev Skupnosti.
One of the objectives of the Regulation (EC) No 1924/2006 is to ensure that health claims are truthful, clear and reliable and useful to the consumer, and that wording and presentation are taken into account in that respect.
Eden od ciljev Uredbe (ES) št. 1924/2006 je zagotoviti, da je zdravstvena trditev resnična, jasna, zanesljiva in za potrošnika uporabna ter da se pri tem upoštevata besedilo in predstavitev trditve.
Therefore, where the wording of claims used by the applicant has the same meaning for consumers as that of an authorised health claim, because they demonstrate the same relationship that exists between a food category, a food or one of its constituents and health, they should be subject to the same conditions of use, as indicated in the Annex to the present Decision.
Kadar ima besedilo trditev, ki ga uporabi vlagatelj, za potrošnike enak pomen kot odobrena zdravstvena trditev, ker predstavljata isto povezavo med kategorijo živila, živilom ali njegovo sestavino in zdravjem, je treba te trditve uporabljati pod istimi pogoji, kot so navedeni v Prilogi k tej odločbi.
The Authority indicated in its opinion that its conclusions could not have been reached without considering the nine studies claimed by the applicant as proprietary.
Agencija je v svojem mnenju navedla, da do ugotovitev ne bi prišla brez upoštevanja devetih študij, za katere je vlagatelj zahteval zakonsko zaščito podatkov.
Following the receipt of the Authority’s opinion, the Commission went back to the applicant for further clarification on the justification provided regarding the nine studies claimed as proprietary and in particular regarding the ‘exclusive right of reference’ as referred to in Article 21(1)(b) of Regulation (EC) No 1924/2006.
Komisija je po prejemu mnenja Agencije vlagatelja prosila za nadaljnje pojasnilo utemeljitve glede devetih študij, za katere je vlagatelj zahteval zakonsko zaščito podatkov, in zlasti glede „izključne pravice sklicevanja“ iz člena 21(1)(b) Uredbe (ES) št. 1924/2006.
All the justifiable information provided by the applicant has been assessed.
Vse upravičljive informacije, ki jih je predložil vlagatelj, so bile ocenjene.
For the seven unpublished studies it is considered that the requirements laid down in Article 21(1) of Regulation (EC) No 1924/2006 are fulfilled.
Za sedem neobjavljenih študij velja, da izpolnjujejo zahteve iz člena 21(1) Uredbe (ES) št. 1924/2006.
Accordingly, the scientific data and other information included in the seven studies may not be used for the benefit of a subsequent applicant for a period of 5 years from the date of authorisation, under the conditions laid down in Article 21(1) of that Regulation.
Zato se znanstveni podatki in druge informacije iz sedmih študij v skladu s pogoji iz člena 21(1) navedene uredbe ne smejo uporabiti v prid poznejšega vlagatelja v petih letih od datuma izdaje dovoljenja.
For the two studies, which had been published prior to the submission of the application for authorisation of the health claim [3], it is considered that as the studies have been published and made available to the public domain, their protection is not justified in the light of the objectives of Regulation (EC) No 1924/2006 among which to protect the investment made by innovators in gathering the information and data supporting an application under that Regulation and accordingly it should not be granted.
Za dve študiji, ki sta bili objavljeni pred predložitvijo vloge za odobritev zdravstvene trditve [3], se šteje, da zaradi objave in omogočenega dostopa javnosti do njiju zakonska zaščita podatkov v zvezi s tema študijama ni utemeljena glede na cilje Uredbe (ES) št. 1924/2006, med katerimi je zaščita naložb inovatorjev v zbiranje informacij in podatkov v podporo uporabi v skladu z navedeno uredbo, in se zato ne sme odobriti.
The comments from the applicant received by the Commission, pursuant to Article 16(6) of Regulation (EC) No 1924/2006, have been considered when setting the measures provided for in this Decision.
Pri določanju ukrepov iz te odločbe so bile upoštevane pripombe, ki jih je vlagatelj poslal Komisiji v skladu s členom 16(6) Uredbe (ES) št. 1924/2006.
The Member States have been consulted,
Opravljeno je bilo posvetovanje z državami članicami –
The health claim set out in the Annex to this Decision shall be included in the Community list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
Zdravstvena trditev iz Priloge k tej odločbi se uvrsti na seznam dovoljenih trditev Skupnosti v skladu s členom 13(3) Uredbe (ES) št. 1924/2006.
The scientific data and other information included in the studies identified in the Annex to this Decision shall be restricted for use for the benefit of the applicant for a period of 5 years from the date of authorisation under the conditions laid down in Article 21(1) of Regulation (EC) No 1924/2006.
Uporaba znanstvenih podatkov in drugih informacij, vključenih v študijah iz Priloge k tej odločbi, se v skladu s pogoji iz člena 21(1) Uredbe (ES) št. 1924/2006 omeji v prid vlagatelja za pet let od datuma izdaje dovoljenja.
This Decision is addressed to Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, United Kingdom
Ta odločba je naslovljena na družbo Provexis Natural Products Ltd., Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, Združeno kraljestvo
The EFSA Journal (2009) 1101, pp. 1-15.
The EFSA Journal (2009) 1101, str. 1–15.
Applicant — Address
Vlagatelj – naslov
Nutrient, substance, food or food category
Hranilo, snov, živilo ali kategorija živil
Claim
Trditev
Conditions of use of the claim
Pogoji uporabe trditve
Conditions and/or restrictions of use of the food and/or additional statement or warning
Pogoji in/ali omejitve uporabe živila in/ali dodatno pojasnilo ali opozorilo
Proprietary data restricted for use for the benefit of the applicant
Zaščiteni podatki, katerih uporaba je omejena v prid vlagatelja
EFSA opinion reference
Referenčno mnenje Evropske agencije za varnost hrane
Provexis Natural Products Ltd, Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, United Kingdom
Provexis Natural Products Ltd., Thames Court, 1 Victoria Street, Windsor, Berkshire, SL4 1YB, Združeno kraljestvo .
Water-Soluble Tomato Concentrate (WSTC) I and II
V vodi topen paradižnikov koncentrat I in II
Water-Soluble Tomato Concentrate (WSTC) I and II helps maintain normal platelet aggregation, which contributes to healthy blood flow
V vodi topen paradižnikov koncentrat I in II pomaga pri ohranjanju normalne agregacije trombocitov, ki je pomembna za zdrav krvni obtok.
Information to the consumer that the beneficial effect is obtained with a daily consumption of 3g WSTC I or 150 mg WSTC II in up to 250 ml of either fruit juices, flavoured drinks or yogurt drinks (unless heavily pasteurised)
Informacija potrošniku, da se koristni učinek doseže z dnevnim uživanjem 3 g v vodi topnega paradižnikovega koncentrata I ali 150 mg v vodi topnega paradižnikovega koncentrata II v do 250 ml sadnih sokov, aromatiziranih pijač ali jogurtovih napitkov (če niso močno pasterizirani)
Manuscript for submission; 2008.
Rokopis za objavo; 2008.
Unpublished, 2007/2008.
Neobjavljeno, 2007/2008.
O’Kennedy, N., Crosbie, L., Whelam, S., Luther, V., Horgan, G., Broom, J.I., Webb, D.J., Duttaroy, A.K., Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans, The American Journal of Clinical Nutrition, 2006, Vol. 84, pp. 561-569 and O’Kennedy N., Crosbie, L., van Lieshout, M., Broom, J.I., Webb, D.J., Duttaroy, A.K., Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans.
O’Kennedy N, Crosbie L, Whelam S, Luther V, Horgan G, Broom JI, Webb DJ, Duttaroy AK, Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans, The American Journal of Clinical Nutrition, 2006, vol. 84, str. 561–569 and O’Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ, Duttaroy AK, Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans.
The American Journal of Clinical Nutrition, 2006, Vol. 84, pp. 570-579.
American Journal of Clinical Nutrition, 2006, vol. 84, str. 570–579.
REC No 02/0269
REC št. 02/0269
REC No 03/0177.
REC št. 03/0177.
REC No 05/S0802/77.
REC št. 05/S0802/77.
REC No 06/S0802/60.
REC št. 06/S0802/60.
REC No 07/S0801/13.
REC št. 07/S0801/13.
Council Decision 2009/981/CFSP
Sklep Sveta 2009/981/SZVP
of 18 December 2009
z dne 18. decembra 2009
There are no longer grounds for keeping one person on the list of persons, entities and bodies to which Common Position 2006/318/CFSP applies,
Ni več razlogov, da bi bila določena oseba še naprej vključena na seznam oseb, subjektov in organov, za katere se uporablja Skupno stališče 2006/318/SZVP –
The person mentioned in the Annex to this Decision shall be removed from the list set out in Annex II to Common Position 2006/318/CFSP.
Oseba, navedena v Prilogi k temu sklepu, se črta s seznama iz Priloge II k Skupnemu stališču 2006/318/SZVP.
Done at Brussels, 18 December 2009.
V Bruslju, 18. decembra 2009
PERSON REFERRED TO IN ARTICLE 1
OSEBA IZ ČLENA 1
Identifying information
Podatki za ugotavljanje identitete
(inc. Ministry)
(vključno z ministrstvom)
Political and Security Committee Decision EUJUST LEX/2/2009
Sklep političnega in varnostnega odbora EUJUST LEX/2/2009
concerning the appointment of the Head of Mission for the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX
o imenovanju vodje misije EUJUST LEX Evropske unije za krepitev pravne države v Iraku
(2009/982/CFSP)
(2009/982/SZVP)
Having regard to Council Joint Action 2009/475/CFSP of 11 June 2009 on the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX, and in particular Article 9(2) thereof,
ob upoštevanju Skupnega ukrepa Sveta 2009/475/SZVP z dne 11. junija 2009 o integrirani misiji EUJUST LEX Evropske unije za krepitev pravne države v Iraku in zlasti člena 9(2) Skupnega ukrepa,
Article 9(2) of Joint Action 2009/475/CFSP authorises the Political and Security Committee to take decisions regarding the appointment of the Head of Mission.
Člen 9(2) Skupnega ukrepa 2009/475/SZVP pooblašča Politični in varnostni odbor, da sprejme odločitve o imenovanju vodje misije.
The High Representative of the Union for Foreign Affairs and Security Policy has proposed that Mr Francisco DÍAZ ALCANTUD be appointed as Head of Mission of EUJUST LEX until 30 June 2010.
Visoka predstavnica Unije za zunanje zadeve in varnostno politiko je predlagala, da se za vodjo misije EUJUST LEX do 30. junija 2010 imenuje g. Francisco DÍAZ ALCANTUD.
Mr Francisco DÍAZ ALCANTUD is hereby appointed as Head of Mission of the European Union Integrated Rule of Law Mission for Iraq, EUJUST LEX, for the period from 1 January 2010 until 30 June 2010.
Francisco DÍAZ ALCANTUD se imenuje za vodjo integrirane misije EUJUST LEX Evropske unije za krepitev pravne države v Iraku za obdobje od 1. januarja 2010 do 30. junija 2010.
This Decision shall be notified to Mr Francisco DÍAZ ALCANTUD.
O tem sklepu se obvesti g. Francisca DÍAZ ALCANTUDA.
It shall take effect on the day of its notification.
Učinkovati začne na dan obestila.
on the granting of State aid by the authorities of the Republic of Lithuania for the purchase of State-owned agricultural land between 1 January 2010 and 31 December 2013
o dodelitvi državne pomoči s strani oblasti Republike Litve za nakup kmetijskih zemljišč v državni lasti med 1. januarjem 2010 in 31. decembrom 2013
Having regard to the Treaty on the Functioning of the European Union and in particular Article 108(2), third subparagraph, thereof,
ob upoštevanju Pogodbe o delovanju Evropske unije in zlasti tretjega pododstavka člena 108(2) Pogodbe,
Having regard to the request made by the Government of the Republic of Lithuania on 23 November 2009,
ob upoštevanju zahteve vlade Republike Litve z dne 23. novembra 2009,
On 23 November 2009, the Republic of Lithuania (hereinafter referred to as ‘Lithuania’) presented to the Council a request for a decision in accordance with the third subparagraph of Article 88(2) of the Treaty establishing the European Community concerning Lithuania’s plan to grant State aid to Lithuanian farmers for the purchase of State-owned agricultural land.
Republika Litva (v nadaljnjem besedilu: Litva) je 23. novembra 2009 Svetu predložila zahtevo za sklep v skladu s tretjim pododstavkom člena 88(2) Pogodbe o ustanovitvi Evropske skupnosti o načrtu Litve za dodelitev državne pomoči litovskim kmetom za nakup kmetijskih zemljišč v državni lasti.
Due to insufficient agricultural incomes, it is difficult to improve the unfavourable area structure of Lithuanian agricultural holdings.
Zaradi nezadostnih kmetijskih prihodkov je težko izboljšati neugodno strukturo površin litovskih kmetijskih gospodarstev.
In 2009, farms with an area of up to 5 hectares made up 52,5 % of all farms.
Leta 2009 so kmetijska gospodarstva s površino do 5 hektarjev predstavljala 52,5 % vseh kmetijskih gospodarstev.
In 2009, the economic and financial crisis substantially decreased producer prices of agricultural products in Lithuania: in the first quarter, the producer prices of agricultural products declined by 27 % compared to the first quarter of 2008, by 25,3 % in the second quarter compared to the second quarter of 2008 and by 8 % in the third quarter compared to the third quarter of 2008.
V Litvi so se proizvodne cene kmetijskih proizvodov leta 2009 zaradi gospodarske in finančne krize močno znižale: v prvem četrtletju so se proizvodne cene kmetijskih proizvodov v primerjavi s prvim četrtletjem v letu 2008 znižale za 27 %, v drugem četrtletju v primerjavi z istim obdobjem v letu 2008 za 25,3 % in v tretjem četrtletju za 8 % v primerjavi s tretjim četrtletjem v letu 2008.
Crop producer prices have been especially significantly hit by this decrease: over the same reference period producer prices of crop products declined accordingly by 33,6 %, 35,7 % and 17,9 %.
To znižanje je še posebej prizadelo proizvodne cene poljščin: v istem referenčnem obdobju so proizvodne cene poljščin padle za 33,6 %, 35,7 % oziroma 17,9 %.
At the end of 2008 and in 2009, in view of the lack of equity capital of farmers and the high interest rates applied by credit institutions on loans for the purchase of agricultural land, the prospects for farmers of taking out loans for investments such as the purchase of agricultural land at market conditions were drastically reduced.
Konec leta 2008 in v letu 2009 so se možnosti kmetov za najemanje posojil za naložbe, kot je nakup kmetijskega zemljišča pod tržnimi pogoji, zaradi pomanjkanja lastniškega kapitala kmetov in visokih obrestnih mer kreditnih institucij na posojila za nakup kmetijskih zemljišč močno zmanjšale.
In the fourth quarter of 2008 and in 2009, credit interest rates on loans for the purchase of agricultural land varied between 9,51 % to 15,99 % per annum.
Letne obrestne mere za kredite za nakup kmetijskih zemljišč so v zadnjem četrtletju leta 2008 in v letu 2009 nihale med 9,51 % in 15,99 %.
The State aid will be provided in two alternative forms: 1) by multiplying the market price of the purchased land by a weighting factor (0,6 or 0,75 for young farmers if all the conditions set in the aid scheme are fulfilled); 2) by selling the State-owned agricultural land on an instalment basis, in which case the aid corresponds to the difference between the actual interest rate paid by the purchaser, which is minimum 5 %, and the interest rate applied by the lending bank.
Državna pomoč bo dodeljena na dva različna načina: (1) tržna cena kupljenega zemljišča bo pomnožena s ponderjem (0,6 ali 0,75 za mlade kmete, če so izpolnjeni vsi pogoji, določeni v shemi pomoči); (2) kmetijska zemljišča v državni lasti se prodajo na obroke; pomoč je v tem primeru razlika med dejansko obrestno mero, ki jo plača kupec ter je najmanj 5 %, in obrestno mero banke, ki daje posojilo.